Lesinurad
Back to searchMolecule Structure
Scientific Name
Lesinurad
Description of the Drug
Lesinurad is a uric acid 1 transporter inhibitor typically used in combination with a xanthine oxidase inhibitor to treat hyperuricemia associated with gout in patients with inadequate control of uric acid levels with xanthine oxidase inhibitor monotherapy.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB11560
http://www.drugbank.ca/drugs/DB11560
Brand Name(s)
Zurampic
Company Owner(s)
Ironwood Pharmaceuticals Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Solute carrier family 22 member 12 | SINGLE PROTEIN | INHIBITOR | CHEMBL6120 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL842962 | |
PharmGKB | PA166160006 | |
DrugBank | DB11560 | |
PubChem | 53465279 | |
LINCS | LSM-45661 | |
DrugCentral | 5075 | |
ChemicalBook | CB32628032 | |
Guide to Pharmacology | 7673 | |
rxnorm | ZURAMPIC | LESINURAD |
ChEBI | 90929 | |
ZINC | ZINC000084757007 |